Mindset Pharma Synthesizes Second Generation Medicinal Psychedelic Compounds Pharmaceutical Investing
Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia Pharmaceutical Investing
Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19 Cannabis Investing News
Rojo Resources Ltd. Announces the Conditional Approval of Reverse Take-over Transaction with Salvation Botanicals Ltd. Cannabis Investing News
Algernon Pharmaceuticals Announces up to $5.0 Million Private Placement Offering of Special Warrants Pharmaceutical Investing
Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial Biotech Investing
Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD Pharmaceutical Investing
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program Pharmaceutical Investing
